2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
and to detect new sequence variants within SPG4 gene in 51 HSP<br />
patients in Estonia . Fifty healthy individuals were used as controls .<br />
The majority <strong>of</strong> patients had pHSP and only five patients had cHSP<br />
form <strong>of</strong> the disease . cHSP was the most frequent in sporadic cases<br />
. All 51 samples were screened with DHPLC and abnormal elution<br />
pr<strong>of</strong>iles were sequenced. Nine changes (G609A, A810G, 1299-1g>c,<br />
1310delA, 1370+215g>c, 1370+202delG, C1503A, 1477-1481del-<br />
GAGAA, 1966insA) in SPG4 gene were detected showing no gender<br />
predisposition . Seven were new and only found in 11 HSP patients,<br />
but two (one new - 1370+215g>c and other previously described -<br />
1370+202delG) were detected both in patients and controls . Only two<br />
mutations (1299-1g>c, C1503A) showed familial segregation, in which<br />
three and two family members were affected, respectively . Other mutations<br />
were found in individuals from different families . In conclusion<br />
we associate above-mentioned seven new mutations with 11 AD-HSP<br />
cases, since new sequence variants were found only in patients compared<br />
to healthy controls . The rest <strong>of</strong> the patients must be checked for<br />
other changes (larger INDELs) in SPG4 and other genes involved in<br />
this disease should be considered for further analysis .<br />
P05.187<br />
in depth investigation <strong>of</strong> -1 frameshifting in expanded cAG<br />
repeat tracts using time-lapse live cell imaging<br />
S. J. Stochmanski 1 , C. Gaspar 1 , D. Rochefort 1 , J. Laganiere 1 , P. Hince 1 , G. Di<br />
Cristo 2 , G. A. Rouleau 1 ;<br />
1 Centre <strong>of</strong> Excellence in Neuromics, CHUM Research Centre, Montréal, QC,<br />
Canada, 2 Centre de Recherche, Hôpital Ste-Justine, Montréal, QC, Canada.<br />
Spinocerebellar ataxia type 3 (SCA3) results from an expansion <strong>of</strong> a<br />
polyglutamine-encoding CAG tract in the ATXN3 gene . We have previously<br />
demonstrated that this expanded CAG tract is subject to -1 ribosomal<br />
frameshifting into the alanine frame, which seems to confer an<br />
increased toxicity, and that the antibiotic anisomycin reduces both -1<br />
frameshifting and cell toxicity . Currently, dual-tagged ATXN3 reporter<br />
constructs were created to express DsRED in the main (glutamine)<br />
frame and EGFP in the -1 (alanine) reading frame, and these reporter<br />
constructs contained either 14 CAG repeats, 89 CAG repeats, or 92<br />
CAA repeats . Constructs were transfected into COS-1 cells as well as<br />
mouse cortical organotypic slice culture preparations, and were monitored<br />
for the production <strong>of</strong> red or green fluorescence signals using<br />
time-lapse live-cell two-wave fluorescent microscopy. Employing this<br />
technique, we have confirmed the occurrence <strong>of</strong> -1 frameshifting for<br />
the CAG89 construct, whereas the constructs bearing wild-type CAG<br />
or expanded CAA repeats did not show significant frameshifting. We<br />
also determined that there is a marked time delay between the onset <strong>of</strong><br />
glutamine-containing protein expression and the production <strong>of</strong> frameshifted<br />
species, as well as a correlation between frameshifitng and cell<br />
death. These findings argue in favour <strong>of</strong> local glutamine codon starvation,<br />
followed by a shift in the reading frame to resume translation <strong>of</strong><br />
the protein in the alanine frame and seem to confirm the implication <strong>of</strong><br />
-1 ribosomal frameshifting in the pathogenesis <strong>of</strong> SCA3 .<br />
P05.188<br />
Quantitative analysis <strong>of</strong> SMN gene based on real-time PcR<br />
M. Šimášková 1 , H. Poláková 2 , L. Kádaši 1,2 ;<br />
1 Comenius University, Faculty <strong>of</strong> Natural Sciences, Department <strong>of</strong> Molecular<br />
Biology, Bratislava, Slovakia, 2 Institute <strong>of</strong> Molecular Physiology and genetics<br />
Slovak Academy <strong>of</strong> Science, Bratislava, Slovakia.<br />
Spinal muscular atrophy (SMA) is an autosomal recessive disorder,<br />
caused by the homozygous absence <strong>of</strong> the survival motor neutron<br />
gene (SMN1) in approximately 94% <strong>of</strong> patients . Since most carriers<br />
have only one SMN1 gene copy, several quantitative analyses have<br />
been used for the SMA carrier detection . We performed a SMN1quantitative<br />
real-time PCR analysis using an allele specific primer for the<br />
carrier detection <strong>of</strong> SMA. We compared the sensitivity, specificity,<br />
advantages and disadvantages recently described in the quantitative<br />
method, using TaqMan probes and a newly developed Plexor TM technology,<br />
which had not previously been used for identifying heterozygotes<br />
. Using a comparative threshold cycle (C T ) method and the DNA<br />
fragment <strong>of</strong> human beta globine gene as a reference gene, the gene<br />
copy number <strong>of</strong> SMN1 was quantified. The sensitivity and specificity<br />
<strong>of</strong> the TaqMan and Plexor TM technologies were similar; moreover,<br />
the assay efficiency was almost ideal when using the Plexor TM technology<br />
. The incidence <strong>of</strong> SMA (1:6000-10000) and the notable carrier<br />
frequency (1:35-50) as well as the severity <strong>of</strong> disease, and the lack <strong>of</strong><br />
effective treatment may justify the implementation <strong>of</strong> such analysis in<br />
DNA diagnostic laboratories .<br />
P05.189<br />
molecular <strong>Genetics</strong> and Epidemiology in spanish<br />
spinocerebellar Ataxia<br />
H. San Nicolás 1 , J. Corral 1 , I. Banchs 1 , L. De Jorge 1 , O. Combarros 2 , J. Berciano<br />
2 , C. Serrano 3 , M. Calopa 4 , A. Matilla 5 , D. Genís 6 , V. Volpini 1 ;<br />
1 Center for Molecular Genetic Diagnosis <strong>of</strong> Hereditary Diseases (CDGM)- IDI-<br />
BELL, Hospitalet de Llobregat, Spain, 2 Dep <strong>of</strong> Neurology. Hosp Univ Marqués<br />
de Valdecilla, Santander, Spain, 3 Dep <strong>of</strong> Neurology. Hosp Sant Joan de Deu,<br />
Martorell, Spain, 4 Dep <strong>of</strong> Neurology. Hosp Univ De Bellvitge. IDIBELL, Hospitalet<br />
de Llobregat, Spain, 5 Health Sciences Research Institute Germans Trias<br />
i Pujol, Badalona, Spain, 6 Dep <strong>of</strong> Neurology. Hosp Univ Josep Trueta, Girona,<br />
Spain.<br />
Autosomal dominant cerebellar ataxias (ADCA) are a clinically and<br />
genetically heterogeneous group <strong>of</strong> neurodegenerative disorders in<br />
which several spinocerebellar ataxia (SCA) genes have been cloned:<br />
SCAs1-3, SCAs6-7, SCA12 and SCA17; sharing a CAG repeat expansion<br />
mutations which generally encodes a polyglutamine tract . In<br />
SCA8 the mutation is an untranslated CTG repeat . We have analyzed<br />
340 unrelated familial and 1,013 sporadic and idiopathic cases <strong>of</strong> SCA .<br />
Over the familial cases 6 .04% were SCA1; 26 .85% SCA2; 32 .89%<br />
SCA3; 7 .38% SCA6; 6 .71% SCA7; 14 .77% SCA8; and 1 .34% SCA17 .<br />
In 22 familial index cases with SCA8 expansions the allele range goes<br />
from 85 to 470 repeats (129 .36% ± 67 .55%; Pearson Coef . =52 .22%) .<br />
Maternal transmissions presented elongations <strong>of</strong> the CTG combined<br />
sequence ranging from +2 to +13 repeats (7 .50 ± 5 .5; Pearson Coef .<br />
= 73 .33%) . In contrast, paternal transmissions presented contractions<br />
ranging from 1 to -17 repeats (-6 .83 ± 7 .51; Pearson Coef = -<br />
109 .93%) . Several giant SCA8 expansions ranges from 401 to 1,126<br />
(N= 9), carried by unaffected adult individuals and being originated<br />
from homozygous SCA8 females with alleles <strong>of</strong> moderate size . In contrast,<br />
the homozygous males have transmitted contracted alleles, as in<br />
heterozygous cases occurs . We have tested 90 individuals from general<br />
population and the distribution <strong>of</strong> SCA8 alleles could be classified<br />
in two groups: 15 to 34 CTGs, with frequency 98% and 77 to 86 CTGs,<br />
with frequency 2% . About 60% <strong>of</strong> familial ADCA cases remained genetically<br />
unclassified. No SCA mutations were detected in the 1,013<br />
isolated and idiopathic cases <strong>of</strong> spinocerebellar ataxia .<br />
P05.190<br />
Novel mutations found in ABcA4 in spanish families<br />
J. Aguirre-Lamban1,2 , R. Riveiro-Alvarez1,2 , D. Cantalapiedra1,2 , M. Garcia-<br />
Hoyos1,2 , E. Vallespin1,2 , A. Avila-Fernandez1,2 , J. Gallego-Merlo1,2 , M. Lopez-<br />
Martinez1,2 , M. Trujillo-Tiebas1,2 , C. Ramos1,2 , C. Ayuso1,2 ;<br />
1 2 Fundacion Jimenez Diaz, Madrid, Spain, Centro de Investigacion Biomedica<br />
en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain.<br />
Introduction: ABCA4 mutations have been associated with Stargardt<br />
disease (STGD) . A few cases with autosomic recessive cone-rod dystrophy<br />
(arCRD) and autosomic recessive retinitis pigmentosa (arRP)<br />
have also been found to have ABCA4 mutations . Comparative genetic<br />
analyses <strong>of</strong> ABCA4 variation and diagnostics have been complicated<br />
by substantial allelic heterogeneity .<br />
Subjects and Methods . 31 unrelated families, were previously studied<br />
with the ABCR400 genotyping microarray . In patients with either none<br />
or only one mutant allele were analysed by dHPLC, sequencing and<br />
multiplex ligation-dependent probe amplification (MLPA). Haplotype<br />
analysis was also performed .<br />
Results . 27 ABCA4 mutations were found in 31 Spanish patients with<br />
the ABCR400 microarray. We confirmed that the p.Arg1129Leu mutation<br />
is the most frequent in Spanish patients. dHPLC allowed us to find<br />
eleven novel mutations and were not found in the 100 chromosomes .<br />
Using both tools, the mutation detection rate obtained was incremented<br />
in a 24 .2% with respect to the use <strong>of</strong> the microarray alone . We<br />
detected 1 .6 % <strong>of</strong> false positives and 1 .6 % <strong>of</strong> false negatives . In 17/31<br />
patients (54 .8%) in which the second or neither mutation was found by<br />
these methodologies, they were studied with MLPA; however no deletion<br />
or duplication was found in these samples . No mutation was found<br />
in 4/31 patients (12 .9%) .<br />
Conclusions . The ABCR400 microarray is a comprehensive screening<br />
tool for genetic variation in patients with ABCR-associated retinal pa-